Increased risk of kidney failure in patients with genetic kidney disorders.
Elliott MD, Vena N, Marasa M, Cocchi E, Bheda S, Bogyo K, Shang N, Zanoni F, Verbitsky M, Wang C, Kolupaeva V, Jin G, Sofer M, Gras Pena R, Canetta PA, Bomback AS, Guay-Woodford LM, Hou J, Gillespie BW, Robinson BM, Klein JB, Rheault MN, Smoyer WE, Greenbaum LA, Holzman LB, Falk RJ, Parsa A, Sanna-Cherchi S, Mariani LH, Kretzler M, Kiryluk K, Gharavi AG; CureGN Consortium.
Elliott MD, et al. Among authors: falk rj.
J Clin Invest. 2024 Sep 3;134(17):e178573. doi: 10.1172/JCI178573.
J Clin Invest. 2024.
PMID: 39225089
Free PMC article.
Clinical Trial.